Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972552 · ClinicalTrials.gov registry record · NA
Watermelon/UBIQuinone Study
A NA study of Kidney Transplantation, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04972552 is a NA study of Kidney Transplantation that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 266-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04972552, a NA study of Kidney Transplantation, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Usual Diet
- DIETARY_SUPPLEMENT coenzyme Q10
- OTHER Watermelon diet
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04972552
The ClinicalTrials.gov registry entry for NCT04972552 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (74% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Transplantation appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT04972552 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04972552 about?
NCT04972552 is a clinical study titled "Watermelon/UBIQuinone Study". The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
What is the current status of trial NCT04972552?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-11-15. Estimated completion is 2026-06-30.
What conditions does trial NCT04972552 study?
This clinical trial studies the following conditions: Kidney Transplantation.
What interventions are being tested in trial NCT04972552?
The interventions under investigation include: Placebo (OTHER), Usual Diet (OTHER), coenzyme Q10 (DIETARY_SUPPLEMENT), Watermelon diet (OTHER).
Who is sponsoring clinical trial NCT04972552?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972552 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
RECRUITING · NA
-
APOL1 Genetic Testing Program for Living Donors
ACTIVE NOT RECRUITING · NA
-
Vitamin D Replacement After Kidney Transplant
COMPLETED · NA
-
Intervention to Improve Adherence in Teen Kidney Transplant
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.